News for Healthier Living

Immunotherapy Boosts Chemotherapy in Combating Stage 3 Colon Cancer

New research led by Mayo Clinic Comprehensive Cancer Center found that adding immunotherapy to chemotherapy after surgery for patients with stage 3 (node-positive) colon cancer -- and with a specific genetic makeup called deficient DNA mismatch repair (dMMR) -- was associated with a 50% reduction in cancer recurrence and death compared to chemotherapy alone.

June 1, 2025


June 14 2025

June 13 2025

June 12 2025

June 11 2025

June 10 2025

June 9 2025

June 8 2025

June 7 2025

June 6 2025

June 5 2025

June 4 2025

June 3 2025

June 2 2025

June 1 2025